This HTML5 document contains 170 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38760078
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2017 научная статья наукова стаття, опублікована в травні 2017 naučni članak teaduslik artikkel мақолаи илмӣ scientific article published on 24 May 2017 artykuł naukowy artikulong pang-agham 2017年论文 vetenskaplig artikel 2017 nî lūn-bûn επιστημονικό άρθρο artigo científico 2017年论文 2017年論文 scientific article published on 24 May 2017 vitskapeleg artikkel artículu científicu espublizáu en 2017 articolo scientifico מאמר מדעי 2017年论文 artigo científico 2017年論文 научни чланак vitenskapelig artikkel 2017年论文 2017年の論文 scienca artikolo wetenschappelijk artikel научна статия artikel ilmiah article científic 2017년 논문 artikull shkencor 2017年論文 tieteellinen artikkeli article scientifique scientific article published on 24 May 2017 articol științific مقالة علمية نشرت في 24 مايو 2017 tudományos cikk vedecký článok vědecký článek artigo científico wissenschaftlicher Artikel 2017年論文 bài báo khoa học 2017年论文 videnskabelig artikel სამეცნიერო სტატია บทความทางวิทยาศาสตร์ научни чланак bilimsel makale article scientific ২৪ মে ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2017年论文 2017年論文
p:P577
wds:Q38760078-63488635-4F73-4F41-AF06-872DF4DCEDBC
wdt:P577
2017-05-24T00:00:00Z
p:P407
wds:Q38760078-510CA101-8232-4EF8-98E9-6D9E827E176D
wdt:P407
wd:Q1860
p:P2860
wds:Q38760078-022DE90C-E451-49C1-8FD2-EAE0BD82FF2B wds:Q38760078-05A1CA6B-142D-4F41-83C3-00DE6142EDA2 wds:Q38760078-05A49C5C-B8AF-46D0-B2B0-C71FECC00F91 wds:Q38760078-2E8CEB19-18AB-4400-9197-6FDBC237D00E wds:Q38760078-33EC1CE7-CCC1-4EFB-B60C-5DC5B42A38AD wds:Q38760078-3571EFDB-C309-4523-8974-B4454FB72E4D wds:Q38760078-3FC4A0E4-F057-4BCD-BDFD-F456FCB109D3 wds:Q38760078-0E875B92-07D3-4E08-A62E-0BC2E1AE85B0 wds:Q38760078-10E7E75B-4FF3-4870-9877-B569433F199A wds:Q38760078-1A110B8C-8545-4B0D-BBD0-9CBE1338F649 wds:Q38760078-24313E9B-F242-464A-92AA-3638A1F20202 wds:Q38760078-6D244444-E17C-43A8-8C7B-A21EEB62FCA6 wds:Q38760078-7FF43A4D-2575-41C2-8B21-5947261D6FCE wds:Q38760078-8DEFA2E9-F45E-4D33-991D-CE9897607404 wds:Q38760078-A464ABCC-CB96-4FE5-94A3-C9F67EB5ECBF wds:Q38760078-A7D149DA-A5DA-493C-AED2-9A060CCECB82 wds:Q38760078-4F9A7DCB-EAAC-4C98-886E-BEF93FEA6EAC wds:Q38760078-52561F80-A9B6-4B88-AACD-09244A479233 wds:Q38760078-5797C0A8-E135-4B58-9E34-7D9C9FE4C932 wds:Q38760078-59B50856-A1E4-49C5-90BD-46372368F348 wds:Q38760078-DBF4207E-4A64-483D-B1C5-CF34DBA41B01 wds:Q38760078-DD64B3ED-000F-46E2-A96E-C2996BF81A2C wds:Q38760078-F874347B-FC7F-4AD2-85AE-18A19BC733ED wds:Q38760078-BB40279E-EB16-47F6-8060-F49B1D64838B wds:Q38760078-C4C6769A-0F53-4DE1-BBF8-FBF18C453515 wds:Q38760078-CA2A3C34-9EAB-4205-8086-3853CFE3613C wds:Q38760078-DA74F1C9-2B79-4802-ABE4-724A840426DB
wdt:P2860
wd:Q35540109 wd:Q37804530 wd:Q37277324 wd:Q30356447 wd:Q40412166 wd:Q36352827 wd:Q38931753 wd:Q84348326 wd:Q36684162 wd:Q57220187 wd:Q26991721 wd:Q35166289 wd:Q38543250 wd:Q38566076 wd:Q38975751 wd:Q28265610 wd:Q42270394 wd:Q26747845 wd:Q38598522 wd:Q29547383 wd:Q38799946 wd:Q40528361 wd:Q29620851 wd:Q40163779 wd:Q35463514 wd:Q37357113 wd:Q35328111
p:P2093
wds:Q38760078-F8F1E88C-368C-4CC9-A515-868A02817178 wds:Q38760078-C9C1E995-D289-4E55-A693-39D9D3928391 wds:Q38760078-B9FF2FEF-2003-4B45-AFDB-6DEB4372EA89 wds:Q38760078-4A60EFC9-012F-42C3-BFF8-9EE5A3FDB9BC wds:Q38760078-4E0E8F6D-2F2C-425E-A036-460037B0DCA4 wds:Q38760078-39051293-5962-40AA-88EA-95461BABC33C wds:Q38760078-297CB5F5-CAE5-487F-8479-19C49ADE0B6C
wdt:P2093
Aaron E Lisberg Jonathan W Goldman Silvia C Formenti Krikor Bornazyan Percy Lee Darlene Veruttipong Edward B Garon
rdfs:label
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
skos:prefLabel
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
schema:name
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
p:P50
wds:Q38760078-121FF421-1C2E-454E-A8A7-83C0DF798DDE
wdt:P50
wd:Q61093657
p:P1476
wds:Q38760078-56AC6059-413D-4834-B841-FB6416EB70E5
wdt:P1476
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
p:P304
wds:Q38760078-B1001C8F-7E89-448C-8CF9-770807865DBD
wdt:P304
895-903
p:P31
wds:Q38760078-0393513B-0F6B-4F2E-BC01-7C8A35AF23AB
wdt:P31
wd:Q13442814
p:P921
wds:Q38760078-58AA49D1-650A-4872-A2FD-664848FC644C wds:Q38760078-C9F149C2-4465-4565-91D9-BCF83F1275FB wds:Q38760078-D6758142-B2AE-48E0-9864-568E35FBC0D8 wds:Q38760078-0E6590BF-ACB9-44E1-BC74-E69C0000C9A6
wdt:P921
wd:Q180507 wd:Q47912 wd:Q5452194 wd:Q13896859
p:P698
wds:Q38760078-0287A5CB-AC8A-4452-B052-A1B57C4A781E
wdtn:P698
n12:28551359
wdt:P698
28551359
p:P1433
wds:Q38760078-3DE0A233-758D-436A-8B22-99573B5B1D2A
wdt:P1433
wd:Q13747613
p:P433
wds:Q38760078-67F856FD-B017-4F5C-B79A-F2B79FA5128C
p:P478
wds:Q38760078-20C32588-6DD4-4095-B6B4-C0F31E833272
wdt:P433
7
wdt:P478
18
p:P356
wds:Q38760078-C6EDC161-A600-437F-AB4B-4964015E2B7E
wdtn:P356
n8:S1470-2045(17)30380-7
wdt:P356
10.1016/S1470-2045(17)30380-7
p:P932
wds:Q38760078-E598FF55-D2CF-4216-ADF4-A92C1E0B87A6
wdt:P932
5538772